category guide

How to Choose Medical PPE for Infection Control

May 2, 2026· 12 min read· AI-generated

How to Choose Medical PPE for Infection Control

A procurement guide to surgical masks, respirators, gloves, gowns, and eye protection — covering standards, performance levels, and the supply-chain pitfalls that became painfully visible after 2020.

What this is and who buys it

Medical personal protective equipment covers a family of disposable and semi-reusable products designed to interrupt the transmission of blood-borne pathogens, respiratory aerosols, and contact contaminants between patients and healthcare workers. The core categories are surgical and procedural masks, N95 respirators, examination and surgical gloves, isolation and surgical gowns, face shields, and goggles. These are not commodity office supplies — they are FDA-regulated medical devices with specific performance standards, and specifying the wrong product for a given procedure level is both a compliance gap and a patient-safety issue.

The primary buyers are hospital infection preventionists, ASC administrators, dental practice owners, clinic managers, and laboratory supervisors. Most facilities replenish PPE on standing purchase orders, GPO contracts, or quarterly competitive bids, with volume scaled to census, procedure mix, and precaution-level distribution — the ratio of standard to contact to airborne precaution days drives demand more than patient headcount alone. Post-pandemic federal guidance has also pushed many facilities toward maintaining 90-day strategic stockpiles for high-demand items, which changes the procurement calculus from "just-in-time" to a hybrid model that requires deliberate shelf-life management.

What makes PPE procurement genuinely complex is the layered regulatory landscape. A single shipment might contain gloves subject to FDA 21 CFR 880.6250, masks governed by 21 CFR 878.4040, and respirators requiring simultaneous FDA clearance and NIOSH approval under 42 CFR Part 84. Each product type carries its own performance standard — ASTM, AAMI, or ISO — and the consequences of procuring a non-compliant product became viscerally clear during COVID-19 when counterfeit and substandard items flooded distribution channels. Understanding these standards before writing a PO is the single most valuable thing a procurement team can do.

Key decision factors

FDA classification and 510(k) verification should be the first filter applied to any PPE vendor, not an afterthought. Non-surgical examination gloves and isolation gowns are Class I devices under FDA 21 CFR 880.6250, meaning they are subject to general controls but do not require premarket notification. Surgical masks, surgical gowns, and surgical N95 respirators are Class II devices under 21 CFR 878.4040 and require either 510(k) clearance or, for N95s, NIOSH TC approval. Before awarding any contract, verify the clearance number directly in FDA's 510(k) database — a vendor's claim of clearance is not equivalent to a verified clearance number.

ASTM F2100 performance level alignment determines whether a surgical mask is actually suited to the procedure where it will be worn. The standard defines three protection levels: Level 1 covers low-fluid-exposure environments like routine exams and general medical care; Level 2 addresses moderate splash exposure; Level 3 is required wherever high fluid exposure is anticipated, such as orthopedic surgery or oral procedures with irrigation. Procuring Level 1 masks for a busy surgical suite to save a fraction of a cent per unit is the kind of false economy that creates liability exposure and real infection-control gaps.

NIOSH TC approval numbers for every N95 purchase are non-negotiable in a clinical setting. NIOSH certifies N95 respirators under 42 CFR Part 84, and each approved model carries a unique TC number that can be cross-referenced in the NIOSH PPE-Info database. KN95 respirators — which meet a Chinese GB 2626 standard — are not NIOSH-approved and are not acceptable clinical substitutes for N95s under OSHA's respiratory protection standard (29 CFR 1910.134). Any distributor representing KN95s as equivalent to N95s for airborne-precaution use is either misinformed or misleading you.

Glove AQL rating and material standard matter because a glove's Acceptable Quality Level quantifies the maximum allowable defect rate in a lot sample. FDA recommends AQL ≤1.5 for sterile surgical gloves and ≤2.5 for medical examination gloves. The relevant material standards are ASTM D6319 for nitrile examination gloves and ASTM D3577 for rubber surgical gloves. Gloves arriving with AQL values above 2.5 — which occasionally happens when distributors source opportunistically — should be rejected for patient-contact use regardless of price.

AAMI PB70 gown classification is the framework hospitals and ASCs must use to match gown liquid-barrier performance to clinical risk. The four levels reflect graduated resistance to fluid penetration: Levels 1 and 2 are appropriate for standard and contact precautions, while Levels 3 and 4 are required in surgical suites and for aerosol-generating procedures such as intubation or bronchoscopy. Critically, AAMI PB70 requires tested performance data — a manufacturer's spec sheet that states a level without citing test method results is not compliant documentation.

Supply chain provenance emerged as a procurement-level concern after COVID-19 exposed how heavily U.S. healthcare depended on single-country import sources. Asking distributors to disclose the domestic-versus-imported manufacturing split for each SKU, and requiring country-of-origin labeling on product and lot documentation, gives procurement teams visibility they previously lacked. For strategic stockpile items in particular, U.S.-manufactured products reduce the lead-time risk that materializes during global supply disruptions.

Fit testing infrastructure for N95 procurement is an OSHA obligation, not a clinical preference. OSHA 29 CFR 1910.134 requires annual fit testing for all staff who wear tight-fitting respirators, and different face geometries respond differently to different respirator facepiece designs. Procuring a single N95 model for a diverse workforce almost guarantees that some employees will not achieve adequate fit. Institutional best practice is to maintain at least two NIOSH-approved N95 models on formulary and budget for annual fit-testing labor and equipment costs as part of the PPE program's true cost.

Shelf life and lot traceability are supply-chain hygiene basics that get overlooked when purchasing is decentralized. N95 respirators typically carry manufacturer-stated shelf lives of three to five years; nitrile gloves are generally rated for three years. Every shipment should arrive with a Certificate of Analysis and lot-traceable documentation. Storage conditions matter — elastomeric glove compounds and electrostatic filtration media in respirators degrade faster than stated shelf life if stored in warm, humid, or UV-exposed environments.

What it costs

Pricing for medical PPE spans an enormous range depending on product type, performance level, material, and volume commitment. The figures below reflect institutional bulk pricing in case quantities; single-box pricing at retail medical supply will be materially higher. Note that pricing for non-public-contract products fluctuates with raw material costs and global demand — treat these as indicative bands, not fixed quotes.

Entry tier ($8–20 per 100-unit box equivalent): Vinyl or latex examination gloves, ASTM Level 1 procedural ear-loop masks, spunbond polypropylene AAMI Level 1 isolation gowns (approximately $0.50–$0.90 per unit in case quantities). Appropriate for low-risk, high-volume general patient contact where procedure-level risk is genuinely low.
Mid tier ($20–60 per 100-unit box equivalent): 4–6 mil nitrile examination gloves meeting ASTM D6319 at AQL ≤2.5, ASTM Level 2–3 surgical masks with fluid resistance documentation, disposable isolation gowns at AAMI Level 2–3 (approximately $0.90–$1.80 per unit). This is the workhorse tier for most hospital floors, ASC procedure rooms, and busy dental practices.
Premium tier ($60–200+ per 100-unit equivalent): Surgical N95 respirators (approximately $1.20–$3.00 per unit at bulk institutional pricing, both FDA-cleared and NIOSH-certified), sterile surgical gloves (AQL ≤1.5, ASTM D3577, approximately $2.00–$5.00 per pair), AAMI Level 3–4 reinforced surgical gowns (approximately $2.50–$5.00 per unit). Required for ORs, aerosol-generating procedures, HCID response, and airborne isolation protocols. Reusable PAPR systems are capital equipment at $500–$1,500 per unit and are not included in these consumable tiers.

Common use cases

The appropriate PPE specification changes significantly depending on where in the facility it is used, what procedures are being performed, and what transmission precaution tier is active. Procurement teams that issue a single blanket specification across all departments tend to over-procure premium items for low-risk areas or, more dangerously, under-specify protection for high-risk ones.

Surgical and procedural suites: ASTM Level 3 surgical masks or surgical N95 respirators; sterile surgical gloves (AQL ≤1.5, ASTM D3577); AAMI PB70 Level 3–4 reinforced gowns; face shields or goggles for splash-intensive procedures.
Medical-surgical floors and general patient care: ASTM Level 2 procedural masks; nitrile examination gloves (4–6 mil, AQL ≤2.5, ASTM D6319); AAMI Level 2 isolation gowns for contact-precaution rooms; N95s for confirmed or suspected airborne-precaution patients.
Dental and oral surgery practices: ASTM Level 3 surgical masks or surgical N95s given aerosol-generating nature of most procedures; heavy nitrile exam gloves; face shields standard at every operatory; AAMI Level 2–3 gowns for AGP-intensive sessions.
Clinical and pathology laboratories: Chemical-resistant or heavy-gauge nitrile gloves; ASTM Level 1–2 masks for splash protection; AAMI Level 2 gowns; safety glasses meeting ANSI Z87.1 for eye protection where respiratory hazard is not the primary concern.

Regulatory and compliance

Understanding the regulatory framework for medical PPE requires tracking two separate federal agencies simultaneously. The FDA regulates PPE as medical devices under 21 CFR Parts 878 and 880, establishing device classification, clearance requirements, and general and special controls. NIOSH, under the CDC, certifies respirators under 42 CFR Part 84, assigning TC approval numbers that are the definitive indicator of respirator performance. OSHA's respiratory protection standard (29 CFR 1910.134) then governs the workplace program — fit testing, medical evaluation, training, and written respiratory protection plans — that sits on top of the equipment procurement decisions. These three regulatory streams intersect at the N95, which must simultaneously satisfy all three agencies' requirements.

For gloves, gowns, and masks, the FDA's quality system regulation (21 CFR Part 820) and the relevant ASTM and AAMI performance standards define what compliant product looks like. Importantly, the FDA does not routinely test PPE products at the border; compliance documentation is primarily the manufacturer's and distributor's responsibility, which is why independent verification — requesting third-party test reports from an accredited laboratory, not just a manufacturer spec sheet — is a meaningful procurement safeguard rather than bureaucratic overhead. Facilities accredited by The Joint Commission or DNV should also be aware that surveyors may request documentation of PPE performance standards during infection control reviews.

Service, training, and total cost of ownership

Unlike capital equipment, PPE does not have a service contract in the traditional sense — but its total cost of ownership extends well beyond the unit purchase price. The institutional cost of a respirator program, for example, includes annual fit-testing labor (typically 15–20 minutes per employee), the cost of the fit-testing device itself (qualitative kits are inexpensive; quantitative PortaCount systems are capital purchases in the $3,000–$8,000 range), and the cost of maintaining two or more approved models on formulary to accommodate diverse facial geometries.

Storage infrastructure is another underappreciated cost. Maintaining a 90-day strategic stockpile of N95s, gloves, and gowns requires dedicated shelving in a climate-controlled, UV-protected environment. Facilities that store PPE in loading docks, unconditioned storerooms, or areas with temperature swings can see elastomeric glove compounds degrade and N95 filtration efficiency drop before the manufacturer-stated shelf life is reached. Building adequate storage into facility planning is less glamorous than negotiating unit price, but it directly affects whether your stockpile is usable when you need it.

Training costs should also be factored in. Gown donning and doffing sequences — particularly for AAMI Level 3–4 gowns in contact-precaution settings — require demonstrated competency, and incorrect doffing is a recognized source of healthcare worker contamination. N95 fit-testing infrastructure must be maintained and staff records updated annually. When evaluating bids, it is reasonable to ask whether the distributor or manufacturer offers in-service training support, particularly when introducing a new N95 model to the formulary.

Red flags to watch for

A distributor offering N95 respirators without a NIOSH TC approval number — or claiming that KN95 masks are "equivalent" for clinical airborne-precaution use — should trigger immediate disqualification. The NIOSH PPE-Info database is publicly searchable; if a TC number is not listed there, the product is not NIOSH-approved regardless of what the packaging states. During COVID-19, fraudulent TC numbers appeared on counterfeit products, so cross-referencing the model name and manufacturer against the database entry, not just the number, is prudent.

Be skeptical of any gown or mask spec sheet that states an AAMI or ASTM performance level without citing the specific test method and result values. Legitimate performance documentation will reference the actual standard (e.g., AAMI PB70, ASTM F1671 for viral penetration) and show passing test values — not just a level number asserted by the manufacturer without supporting data.

Unusually low pricing — particularly for N95s priced below $0.80 per unit during normal (non-crisis) market conditions, or nitrile gloves priced significantly below the mid-tier range — warrants verification of the CoA and, ideally, an independent third-party test report before committing to a large PO. Price compression in the PPE market has historically correlated with quality shortcuts: thinner glove gauge, lower filtration efficiency, or misrepresented performance levels.

Finally, watch for distributors who cannot provide lot traceability documentation linking each shipment to a specific manufacturing batch. Lot traceability is not a bureaucratic nicety — it is the mechanism by which a facility can act on a recall, identify affected inventory, and remove compromised product from service before it reaches a patient encounter.

Questions to ask vendors

Can you provide the FDA 510(k) clearance number and/or NIOSH TC approval number for each SKU, and confirm these are verifiable in the respective FDA and NIOSH public databases?
For each mask and gown SKU, can you supply third-party test reports (not manufacturer self-declarations) confirming ASTM F2100 performance level or AAMI PB70 liquid barrier level?
What is the domestic versus imported manufacturing split for your top-volume PPE SKUs, and what is the country of origin for each?
What lot traceability documentation — including Certificate of Analysis — accompanies each shipment, and what is your process for notifying customers in the event of a product recall?
What are the stated shelf lives and required storage conditions for each product category, and how do you handle shelf-life warranty claims for product stored per specification that degrades prematurely?
For N95 models: how many distinct NIOSH-approved models do you carry, and can you provide filtration efficiency test data across multiple facepiece sizes to support our fit-testing program?

Alternatives

The primary structural alternatives in PPE procurement are not competing products but competing supply strategies, each with genuine tradeoffs. GPO (Group Purchasing Organization) contracts offer pre-negotiated pricing with vetted manufacturers and can significantly reduce administrative burden for high-volume, standardized SKUs like examination gloves and procedural masks. The tradeoff is formulary constraint — GPO contracts may not include every performance level or material type your facility needs, and the lowest contract price does not always correspond to the lowest total cost if the product spec falls short of your procedure requirements.

Reusable versus disposable PPE: Reusable gowns (typically polyester or polypropylene blends laundered per AAMI guidance) can reduce per-use cost over a lifecycle and lower single-use waste volumes. The tradeoff is the laundering infrastructure, turnaround time, and validation burden of ensuring washed garments retain their rated barrier performance. Reusable gowns are worth evaluating for high-volume surgical suites; they are impractical for isolation-precaution use where contaminated garments require immediate disposal.
Stockpile versus just-in-time purchasing: A hybrid model — maintaining a 60–90-day strategic reserve for highest-criticality items (surgical N95s, Level 3–4 gowns) while using just-in-time delivery for high-turnover commodity items (examination gloves, Level 1 masks) — balances carrying costs against supply disruption risk. Facilities that went into 2020 with no strategic stockpile paid 5–10× spot pricing during the shortage period.
Domestic sourcing premium: U.S.-manufactured PPE typically carries a 15–30% price premium over equivalent imported product under normal market conditions. For strategic stockpile items, that premium buys supply-chain resilience that is genuinely difficult to quantify until a disruption occurs. For day-to-day commodity consumption, the calculus is more ambiguous and should weigh your facility's risk tolerance and budget constraints.

Sources

No source articles were available for this guide. The regulatory references below are primary sources that procurement teams can consult directly.

Browse vendors in

PPE

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.